legal and technical requirements of emerging sustainability regulations and translating them into business requirements... as mentioned above You will also conduct research on legal topics, develop new service offerings in the field and be involved...
Deine Aufgaben Zur Unterstützung unserer Legal-Abteilung suchen wir eine zuverlässige und motivierte Persönlichkeit... als Anwalt oder Jurist (m/w/d) im Bereich Legal und Compliance. Du bist zuständig für die Beratung und Unterstützung...
voice matters. The Position Legal Counsel - Roche Diagnostics Solutions - Personalized Healthcare Solutions (PHCS... We are looking for an experienced in-house lawyer to join the RDS Legal Team as soon as possible. You will be part of a global network of legal...
in nutrition Strong knowledge of legal and data protection matters in regards to clinical trials Excellent communication... in nutrition Strong knowledge of legal and data protection matters in regards to clinical trials Excellent communication...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »